The DOI matches its Crossref record; 211 of the 211 references it cites were found in a registry or an index.
Atypical aging in down syndrome
Abstract
At present, there may be over 210,000 people with Down syndrome (DS) over the age of 55 in the United States (US) who have significant needs for augmented services due to circumstances related to ordinary and/or pathological aging. From 1979 through 2003, the birth prevalence of DS rose from 9.0 to 11.8 (31.1%) per 10,000 live births in 10 representative US regions. This increase, largely due to women conceiving after age 35, portends an ever‐growing population of people with DS who may be subject to pathogenic aging. Whereas Trisomy 21 is one of the most widespread genetic causes of intellectual disability (ID), it still is one of the least understood of all genetic ID syndromes. While longevity in people with DS has improved appreciably in as modest a period as 30 years, age‐specific risk for mortality still is considerably increased compared both with other people with ID or with the typically developing population. The penetrance of the phenotype is widely distributed, even though a consistent genotype is assumed in 95% of the cases. Some, but not all body systems, exhibit signs of premature or accelerated aging. This may be due to both genetic and epigenetic inheritance. We now know that the long‐term outcome for people with DS is not as ominous as once contemplated; a number of people with DS are living into their late 60s and 70s with few if any major signs of pathogenic aging. Alzheimer's disease (AD), a devastating disease that robs a person of their memory, abilities and personality, is particularly common in elder adults with DS, but is not a certainty as originally thought, some 20% to 30% of elder adults with DS might never show any, or at most mild signs of AD. DS has been called a mature well‐understood syndrome, not in need of further research or science funding. We are only beginning to understand how epigenetics affects the phenotype and it may be feasible in the future to alter the phenotype through epigenetic interventions. This chapter is divided into two sections. The first section will review typical and atypical aging patterns in somatic issues in elder adults with DS; the second section will review the multifaceted relationship between AD and DS. © 2013 Wiley Periodicals, Inc. Dev Disabil Res Rev 2013;18:51–67.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Aging: a theory based on free radical and radiation chemistry
Harman, D. (1956) · Journal of Gerontology · doi:10.1093/geronj/11.3.298 · Cited by 8,567
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484
Epidemiology of Alzheimer disease
Reitz, C., Brayne, C., & Mayeux, R. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.2 · Cited by 1,675
Amyloid β Protein Gene: cDNA, mRNA Distribution, and Genetic Linkage Near the Alzheimer Locus
Tanzi, R. E., Gusella, J. F., Watkins, P. C., Bruns, G. A. P., St George-Hyslop, P., Van Keuren, M. L., Patterson, D., Pagan, S., Kurnit, D. M., & Neve, R. L. (1987) · Science · doi:10.1126/science.2949367 · Cited by 1,611
Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Cardiology in Review · doi:10.1097/01.crd.0000380842.14048.7e · Cited by 1,600
Roizen, N. J., & Patterson, D. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12987-x · Cited by 1,331
Farris, W., Mansourian, S., Chang, Y., Lindsley, L., Eckman, E. A., Frosch, M. P., Eckman, C. B., Tanzi, R. E., Selkoe, D. J., & Guénette, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0230450100 · Cited by 1,286
Prevalence and Clinical Outcome of Mitral-Valve Prolapse
Freed, L. A., Levy, D., Levine, R. A., Larson, M. G., Evans, J. C., Fuller, D. L., Lehman, B., & Benjamin, E. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907013410101 · Cited by 1,169
Occurrence of neuropathological changes and dementia of Alzheimer’s disease in Down’s syndrome
Wisniewski, K. E., Wisniewski, H. M., & Wen, G. Y. (1985) · Annals of Neurology · doi:10.1002/ana.410170310 · Cited by 1,159
Oxidative Stress, Mitochondrial Dysfunction, and Aging
Cui, H., Kong, Y., & Zhang, H. (2012) · Journal of Signal Transduction · doi:10.1155/2012/646354 · Cited by 1,022
Estrogen Therapy in Postmenopausal Women: Effects on Cognitive Function and Dementia
Yaffe, K., Sawaya, G., Lieberburg, I., & Grady, D. (1998) · JAMA · doi:10.1001/jama.279.9.688 · Cited by 941
2011 Alzheimer's disease facts and figures
Alzheimer's Association (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.02.004 · Cited by 908
Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study
Yang, Q., Rasmussen, S. A., & Friedman, J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08092-3 · Cited by 847
Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease
Villemagne, V. L., Pike, K. E., Chételat, G., Ellis, K. A., Mulligan, R. S., Bourgeat, P., Ackermann, U., Jones, G., Szoeke, C., Salvado, O., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22248 · Cited by 833
(1959) · PubMed · Cited by 820
Normal and Abnormal Biology of the beta-Amyloid Precursor Protein
Selkoe, D. J. (1994) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.17.030194.002421 · Cited by 818
Deaths: preliminary data for 2002.
Kochanek, K. D., & Smith, B. L. (2004) · PubMed · Cited by 700
Aging effects on DNA methylation modules in human brain and blood tissue
Horvath, S., Zhang, Y., Langfelder, P., Kahn, R. S., Boks, M. P., van Eijk, K., van den Berg, L. H., & Ophoff, R. A. (2012) · Genome Biology · doi:10.1186/gb-2012-13-10-r97 · Cited by 645
Mechanisms of tau-induced neurodegeneration
Iqbal, K., Liu, F., Gong, C.-X., Alonso, A. D. C., & Grundke-Iqbal, I. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0486-3 · Cited by 628
Observations on an Ethnic Classification of Idiots
Down, J. L. H. (1867) · Journal of Mental Science · doi:10.1192/bjp.13.61.121 · Cited by 587
Prevalence of Cataract and Pseudophakia/Aphakia Among Adults in theUnited States
(2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.487 · Cited by 577
Smith, S. C., Jr. (2005) · The University of North Carolina at Chapel Hill University Libraries · doi:10.17615/x6gg-7674 · Cited by 546
Invited Review: Theories of aging
Weinert, B. T., & Timiras, P. S. (2003) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00288.2003 · Cited by 528
Protective actions of sex steroid hormones in Alzheimer’s disease
Pike, C. J., Carroll, J. C., Rosario, E. R., & Barron, A. M. (2009) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2009.04.015 · Cited by 522
Saunders, A. M., Roses, A. D., Pericak-Vance, M. A., Dole, K. C., Strittmatter, W. J., Schmechel, D. E., Szymanski, M. H., McCown, N., Manwaring, M. G., Schmader, K., et al. (1993) · The Lancet · doi:10.1016/0140-6736(93)91709-u · Cited by 498
Apolipoprotein E, Dementia, and Cortical Deposition of β-Amyloid Protein
Polvikoski, T., Sulkava, R., Haltia, M., Kainulainen, K., Vuorio, A., Verkkoniemi, A., Niinistö, L., Halonen, P., & Kontula, K. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511093331902 · Cited by 493
The four ages of Down syndrome
Bittles, A. H., Bower, C., Hussain, R., & Glasson, E. J. (2007) · The European Journal of Public Health · doi:10.1093/eurpub/ckl103 · Cited by 492
DNA damage, cellular senescence and organismal ageing: causal or correlative?
Chen, J.-H., Hales, C. N., & Ozanne, S. E. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm681 · Cited by 476
The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception
Weiner, M. W., Veitch, D. P., Aisen, P. S., Beckett, L. A., Cairns, N. J., Green, R. C., Harvey, D., Jack, C. R., Jagust, W., Liu, E., et al. (2012) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.09.172 · Cited by 476
Infections and immunodeficiency in Down syndrome
Ram, G., & Chinen, J. (2011) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2011.04335.x · Cited by 465
Plasma Aβ1–40 and Aβ1–42 and the risk of dementia: a prospective case-cohort study
van Oijen, M., Hofman, A., Soares, H. D., Koudstaal, P. J., & Breteler, M. M. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70501-4 · Cited by 458
Clinical, social, and ethical implications of changing life expectancy in Down syndrome
Bittles, A., & Glasson, E. (2004) · Developmental Medicine & Child Neurology · doi:10.1017/s0012162204000441 · Cited by 452
The Influence of Intellectual Disability on Life Expectancy
Bittles, A. H., Petterson, B. A., Sullivan, S. G., Hussain, R., Glasson, E. J., & Montgomery, P. D. (2002) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/57.7.m470 · Cited by 450
Salmon, A. B., Richardson, A., & Pérez, V. I. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.12.015 · Cited by 446
Plasma Aβ40 and Aβ42 and Alzheimer’s disease: Relation to age, mortality, and risk
Mayeux, R., Honig, L. S., Tang, M.-X., Manly, J., Stern, Y., Schupf, N., & Mehta, P. D. (2003) · Neurology · doi:10.1212/01.wnl.0000091890.32140.8f · Cited by 434
The apolipoprotein ε4 allele in patients with Alzheimer's disease
Mayeux, R., Stern, Y., Ottman, R., Tatemichi, T. K., Tang, M., Maestre, G., Ngai, C., Tycko, B., & Ginsberg, H. (1993) · Annals of Neurology · doi:10.1002/ana.410340527 · Cited by 414
Molecular mapping of alzheimer‐type dementia in Down's syndrome
Prasher, V. P., Farrer, M. J., Kessling, A. M., Fisher, E. M. C., West, R. J., Barber, P. C., & Butler, A. C. (1998) · Annals of Neurology · doi:10.1002/ana.410430316 · Cited by 414
Korbel, J. O., Tirosh-Wagner, T., Urban, A. E., Chen, X.-N., Kasowski, M., Dai, L., Grubert, F., Erdman, C., Gao, M. C., Lange, K., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813248106 · Cited by 399
Oxidative damage, ageing, and life-history evolution: where now?
Selman, C., Blount, J. D., Nussey, D. H., & Speakman, J. R. (2012) · Trends in Ecology & Evolution · doi:10.1016/j.tree.2012.06.006 · Cited by 385
The endoplasmic reticulum stress response in aging and age-related diseases
Brown, M. K., & Naidoo, N. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00263 · Cited by 376
Sethupathy, P., Borel, C., Gagnebin, M., Grant, G. R., Deutsch, S., Elton, T. S., Hatzigeorgiou, A. G., & Antonarakis, S. E. (2007) · The American Journal of Human Genetics · doi:10.1086/519979 · Cited by 361
MANN, D. M. A., YATES, P. O., & MARCYNIUK, B. (1984) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1984.tb00351.x · Cited by 345
The epigenetics of cancer etiology
Feinberg, A. P. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2004.06.005 · Cited by 337
A Chromosome 21 Critical Region Does Not Cause Specific Down Syndrome Phenotypes
Olson, L. E., Richtsmeier, J. T., Leszl, J., & Reeves, R. H. (2004) · Science · doi:10.1126/science.1098992 · Cited by 330
Down syndrome: Cognitive phenotype
Silverman, W. (2007) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.20156 · Cited by 324
Zandi, P. P. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.2.217 · Cited by 310
Talens, R. P., Christensen, K., Putter, H., Willemsen, G., Christiansen, L., Kremer, D., Suchiman, H. E. D., Slagboom, P. E., Boomsma, D. I., & Heijmans, B. T. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00835.x · Cited by 300
Improved National Prevalence Estimates for 18 Selected Major Birth Defects--United States, 1999-2001
(2006) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.295.6.618 · Cited by 299
Keyes, K. M., Utz, R. L., Robinson, W., & Li, G. (2010) · Social Science & Medicine · doi:10.1016/j.socscimed.2009.12.018 · Cited by 292
Population-based study of the prevalence and presentation of dementia in adults with Down's syndrome
Holland, A. J., Hon, J., Huppert, F. A., Stevens, F., & Watson, P. (1998) · British Journal of Psychiatry · doi:10.1192/bjp.172.6.493 · Cited by 288
Congenital Heart Surgery Outcomes in Down Syndrome: Analysis of a National Clinical Database
Fudge, J. C., Li, S., Jaggers, J., O'Brien, S. M., Peterson, E. D., Jacobs, J. P., Welke, K. F., Jacobs, M. L., Li, J. S., & Pasquali, S. K. (2010) · Pediatrics · doi:10.1542/peds.2009-3245 · Cited by 282
Thyroid dysfunction in Down's syndrome: relation to age and thyroid autoimmunity
Karlsson, B., Gustafsson, J., Hedov, G., Ivarsson, S.-A., & Anneren, G. (1998) · Archives of Disease in Childhood · doi:10.1136/adc.79.3.242 · Cited by 279
Molecular genetic analysis of Down syndrome
Patterson, D. (2009) · Human Genetics · doi:10.1007/s00439-009-0696-8 · Cited by 278
Alzheimer's disease in Down syndrome: Neurobiology and risk
Zigman, W. B., & Lott, I. T. (2007) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.20163 · Cited by 278
Self-citationAβ42 is More Rigid than Aβ40 at the C Terminus: Implications for Aβ Aggregation and Toxicity
Yan, Y., & Wang, C. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.09.046 · Cited by 273
GENETICS AND MENTAL RETARDATION SYNDROMES: A NEW LOOK AT BEHAVIOR AND INTERVENTIONS
Dykens, E. M. (2000) · DigitalGeorgetown (Georgetown University Library) · Cited by 269
Robakis, N., Wisniewski, H., Jenkins, E., Devine-Gage, E., Houck, G., Yao, X.-L., Ramakrishna, N., Wolfe, G., Silverman, W., & Ted Brown, W. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91754-5 · Cited by 268
Dementia and mortality in persons with Down’s syndrome
Coppus, A., Evenhuis, H., Verberne, G. ‐., Visser, F., Van Gool, P., Eikelenboom, P., & Van Duijin, C. (2006) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.2006.00842.x · Cited by 260
Holland, A. J., Hon, J., Huppert, F. A., & Stevens, F. (2000) · Journal of Intellectual Disability Research · doi:10.1046/j.1365-2788.2000.00263.x · Cited by 259
Prevalence of Down Syndrome Among Children and Adolescents in 10 Regions of the United States
Shin, M., Besser, L. M., Kucik, J. E., Lu, C., Siffel, C., Correa, A., & Collaborative, T. C. A. M. P. A. S. (. (2009) · Pediatrics · doi:10.1542/peds.2009-0745 · Cited by 258
Metabolic Implications of Menopause
Polotsky, H., & Polotsky, A. (2010) · Seminars in Reproductive Medicine · doi:10.1055/s-0030-1262902 · Cited by 254
Korenberg, J. R., Kawashima, H., Pulst, S. M., Ikeuchi, T., Ogasawara, N., Yamamoto, K., Schonberg, S. A., West, R. J., Allen, L., & Magenis, E. (1990) · PubMed · Cited by 242
Understanding the Basis for Down Syndrome Phenotypes
Roper, R. J., & Reeves, R. H. (2006) · PLoS Genetics · doi:10.1371/journal.pgen.0020050 · Cited by 233
Perneczky, R., Pohl, C., Sorg, C., Hartmann, J., Tosic, N., Grimmer, T., Heitele, S., & Kurz, A. (2006) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1444 · Cited by 229
EARLY SENILE DEMENTIA IN MONGOLOID IDIOCY
JERVIS, G. A. (1948) · American Journal of Psychiatry · doi:10.1176/ajp.105.2.102 · Cited by 227
Neurological phenotypes for Down syndrome across the life span
Lott, I. T. (2012) · Progress in Brain Research · doi:10.1016/b978-0-444-54299-1.00006-6 · Cited by 225
The Metabolic Syndrome and Development of Cognitive Impairment Among Older Women
Yaffe, K., Weston, A. L., Blackwell, T., & Krueger, K. A. (2009) · Archives of Neurology · doi:10.1001/archneurol.2008.566 · Cited by 220
Alzheimer disease and Down syndrome: factors in pathogenesis
Lott, I. T., & Head, E. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.08.005 · Cited by 212
Hearing Loss in Older Adults: Who's Listening?
Lin, F. R. (2012) · JAMA · doi:10.1001/jama.2012.321 · Cited by 209
Prevalence of Dementia and Impact on Intellectual Disability Services
Janicki, M. P., & Dalton, A. J. (2000) · Mental Retardation · doi:10.1352/0047-6765(2000)038<0276:podaio>2.0.co;2 · Cited by 195
Recent Developments in Cholinesterases Inhibitors for Alzheimers Disease Treatment
Musial, A., Bajda, M., & Malawska, B. (2007) · Current Medicinal Chemistry · doi:10.2174/092986707782023217 · Cited by 195
Genetic and host factors for dementia in Down's syndrome
Schupf, N. (2002) · British Journal of Psychiatry · doi:10.1192/bjp.180.5.405 · Cited by 188
(1997) · PubMed · Cited by 184
[Mongolism; a chromosomal disease (trisomy)].
LEJEUNE, J., Turpin, R., & Gautier, M. (1959) · PubMed · Cited by 183
Ball, S. L., Holland, A. J., Hon, J., Huppert, F. A., Treppner, P., & Watson, P. C. (2006) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1545 · Cited by 182
Neuropathology of Organic Brain Syndromes Associated with Aging
Malamud, N. (1972) · Advances in Behavioral Biology · doi:10.1007/978-1-4684-8503-5_6 · Cited by 181
Oxidative Stress and Down Syndrome: A Route toward Alzheimer-Like Dementia
Perluigi, M., & Butterfield, D. A. (2012) · Current Gerontology and Geriatrics Research · doi:10.1155/2012/724904 · Cited by 181
Shepardson, N. E. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.242 · Cited by 181
Down's syndrome: an atheroma-free model?
Murdoch, J. C., Rodger, J. C., Rao, S. S., Fletcher, C. D., & Dunnigan, M. G. (1977) · BMJ · doi:10.1136/bmj.2.6081.226 · Cited by 179
Health Conditions Associated with Aging and End of Life of Adults with Down Syndrome
Esbensen, A. J. (2010) · International Review of Research in Mental Retardation · doi:10.1016/s0074-7750(10)39004-5 · Cited by 176
Hanney, M., Prasher, V., Williams, N., Jones, E. L., Aarsland, D., Corbett, A., Lawrence, D., Yu, L.-M., Tyrer, S., Francis, P. T., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61676-0 · Cited by 164
Indicators of amyloid burden in a population-based study of cognitively normal elderly
Mielke, M. M., Wiste, H. J., Weigand, S. D., Knopman, D. S., Lowe, V. J., Roberts, R. O., Geda, Y. E., Swenson-Dravis, D. M., Boeve, B. F., Senjem, M. L., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e31826e2696 · Cited by 163
The molecular biology of senile plaques and neurofibrillary tangles in Alzheimer's disease.
Armstrong, R. A. (2009) · PubMed · Cited by 160
Trisomy represses ApcMin -mediated tumours in mouse models of Down’s syndrome
Sussan, T. E., Yang, A., Li, F., Ostrowski, M. C., & Reeves, R. H. (2008) · Nature · doi:10.1038/nature06446 · Cited by 160
Down syndrome and Alzheimer's disease: A link between development and aging
Lott, I. T., & Head, E. (2001) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.1025 · Cited by 158
Health care concerns and guidelines for adults with Down syndrome
Allen, M. I. V., Fung, J., & Jurenka, S. B. (1999) · American Journal of Medical Genetics · Cited by 154
Serum Estrogen Levels, Cognitive Performance, and Risk of Cognitive Decline in Older Community Women
Yaffe, K. S., Grady, D. G., Pressman, A. R., & Cummings, S. (1998) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1998.tb02713.x · Cited by 152
Prasher, V. P., Huxley, A., Haque, S. M., & the Down syndrome Ageing Study Group (2002) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.587 · Cited by 152
Twenty-year trends in prevalence and survival of Down syndrome
Irving, C. A., Basu, A. P., Richmond, S. W. J., Burn, J., & Wren, C. (2008) · European Journal of Human Genetics · doi:10.1038/ejhg.2008.122 · Cited by 149
Hyman, B. T., West, H. L., Rebeck, G. W., Lai, F., & Mann, D. M. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540280059019 · Cited by 148
(1996) · PubMed · Cited by 140
Plasma Amyloid-β as a Biomarker in Alzheimer's Disease: The AIBL Study of Aging
Lui, J. K., Laws, S. M., Li, Q., Villemagne, V. L., Ames, D. J., Brown, B. M., Bush, A. I., Ruyck, K. D., Dromey, J. R., Ellis, K. A., et al. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-090249 · Cited by 137
Tumour angiogenesis is reduced in the Tc1 mouse model of Down’s syndrome
Reynolds, L. E., Watson, A. R., Baker, M., Jones, T. A., D’Amico, G., Robinson, S. D., Joffre, C., Garrido‐Urbani, S., Rodrı́guez-Manzaneque, J. C., Martino‐Echarri, E., et al. (2010) · Nature · doi:10.1038/nature09106 · Cited by 137
Vilardell, M., Rasche, A., Thormann, A., Maschke-Dutz, E., Jurado, L. A. P., Lehrach, H., & Herwig, R. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-229 · Cited by 137
Down syndrome and dementia: A randomized, controlled trial of antioxidant supplementation
Lott, I. T., Doran, E., Nguyen, V. Q., Tournay, A., Head, E., & Gillen, D. L. (2011) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.34114 · Cited by 136
Early menopause in women with Down's syndrome
Schupf, N., Zigman, W. B., Kapell, D., Lee, J. H., Kline, J. K., & Levin, B. L. (1997) · Journal of Intellectual Disability Research · doi:10.1046/j.1365-2788.1997.03838.x · Cited by 135
Self-citationLIFE EXPECTANCY IN DOWN SYNDROME ADULTS
Baird, P. A., & Sadovnick, A. S. D. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90881-1 · Cited by 134
Immunological features of Down's syndrome: a review
Nespoli, L., BURGIO, G. R., Ugazio, A. G., & Maccario, R. (1993) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.1993.tb00324.x · Cited by 130
Antioxidant Vitamin Supplement Use and Risk of Dementia or Alzheimer's Disease in Older Adults
Gray, S. L., Anderson, M. L., Crane, P. K., Breitner, J. C. S., McCormick, W., Bowen, J. D., Teri, L., & Larson, E. (2008) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01531.x · Cited by 127
Prasher, V. P. (1995) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.930100106 · Cited by 126
Endocrine and musculoskeletal abnormalities in patients with Down syndrome
Hawli, Y. M. A., Nasrallah, M., & Fuleihan, G. E. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.80 · Cited by 116
Altered DNA Methylation in Leukocytes with Trisomy 21
Kerkel, K., Schupf, N., Hatta, K., Pang, D. I., Salas, M. C., Kratz, A. F., Minden, M. D., Murty, V. V. V. S., Zigman, W. B., Mayeux, R. P., et al. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001212 · Cited by 114
Self-citationCossarizza, A., Monti, D., Montagnani, G., Ortolani, C., Masi, M., Zannotti, M., & Franceschi, C. (2005) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320370743 · Cited by 112
Survival in Elderly Persons with Down Syndrome
Coppus, A. M. W., Evenhuis, H. M., Verberne, G., Visser, F. E., Oostra, B. A., Eikelenboom, P., van Gool, W. A., Janssens, A. C. J. W., & van Duijn, C. M. (2008) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2008.01999.x · Cited by 112
Earlier onset of Alzheimer's disease in men with Down syndrome
Schupf, N., Kapell, D., Nightingale, B., Rodriguez, A., Tycko, B., & Mayeux, R. P. (1998) · Neurology · doi:10.1212/wnl.50.4.991 · Cited by 111
Dermatological manifestations of Down's syndrome
Madan, V., Williams, J. D. L., & Lear, J. T. (2006) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.2006.02164.x · Cited by 110
Down syndrome: orthopedic issues
Mik, G., Gholve, P. A., Scher, D. M., Widmann, R. F., & Green, D. W. (2008) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e3282f35f19 · Cited by 109
Onset of dementia is associated with age at menopause in women with Down's syndrome
Schupf, N., Pang, D. I., Patel, B. N., Silverman, W. P., Schubert, R., Lai, F., Kline, J. K., Stern, Y., Ferin, M., Tycko, B., et al. (2003) · Annals of Neurology · doi:10.1002/ana.10677 · Cited by 108
Down Syndrome and Thyroid Disorders: A Review
Prasher, V. P. (1999) · Down Syndrome Research and Practice · doi:10.3104/reviews.95 · Cited by 106
Survival among people with Down syndrome: a nationwide population-based study in Denmark
Zhu, J. L., Hasle, H., Correa, A., Schendel, D., Friedman, J. M., Olsen, J., & Rasmussen, S. A. (2012) · Genetics in Medicine · doi:10.1038/gim.2012.93 · Cited by 106
APOE genotype and gender effects on Alzheimer disease in 100 adults with Down syndrome
Lai, F., Kammann, Η., Rebeck, G. W., Anderson, A. J., Chen, Y., & Nixon, R. A. (1999) · Neurology · doi:10.1212/wnl.53.2.331 · Cited by 105
Estrogen restores cognition and cholinergic phenotype in an animal model of Down syndrome
Granholm, A., Ford, K. A., Hyde, L. A., Bimonte, H. A., Hunter, C. L., NELSON, M., Albeck, D. S., Sanders, L., Mufson, E. J., & Crnic, L. S. (2002) · Physiology & Behavior · doi:10.1016/s0031-9384(02)00884-3 · Cited by 104
Elevated Plasma β-Amyloid Peptide Aβ42 Levels, Incident Dementia, and Mortality in Down Syndrome
Schupf, N., Patel, B. N., Pang, D. I., Zigman, W. B., Silverman, W. P., Mehta, P. D., & Mayeux, R. P. (2007) · Archives of Neurology · doi:10.1001/archneur.64.7.1007 · Cited by 103
Self-citationSrikanth, R., Cassidy, G., Joiner, C., & Teeluckdharry, S. (2010) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.2010.01346.x · Cited by 103
Ellis, J., Tan, H. K., Gilbert, R. E., Muller, D. P. R., Henley, W., Moy, R. J., Pumphrey, R., Ani, C. C., Davies, S., Edwards, V., et al. (2008) · BMJ · doi:10.1136/bmj.39465.544028.ae · Cited by 102
Kalmuc Idiocy: Report of a Case with Autopsy
Fraser, J., & Mitchell, A. (1876) · Journal of Mental Science · doi:10.1192/bjp.22.98.169 · Cited by 101
Down Syndrome and Dementia: Seizures and Cognitive Decline
Lott, I. T., Doran, E. W., Nguyen, V. Q., Tournay, A. E., Movsesyan, N., & Gillen, D. L. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-111613 · Cited by 100
Down's Syndrome, Aging, and Alzheimer's Disease: A Clinical Review*
Lott, I. T. (1982) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1982.tb26840.x · Cited by 98
Prasher, V. P. (2004) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1077 · Cited by 97
Premature regression of adults with Down syndrome.
Zigman, W. B., Schupf, N., Lubin, R. A., & Silverman, W. P. (1987) · PubMed · Cited by 95
Self-citationRoyston, M. C., Mann, D. M. A., Pickering-Brown, S. M., Owen, F., Perry, R., Raghavan, R., Khin-IMu, C., Tyrer, S. P., Day, K. A., Crook, R., et al. (1994) · Neuroreport · doi:10.1097/00001756-199412000-00044 · Cited by 94
Onset of dementia is associated with apolipoprotein E ε4 in Down's syndrome
Schupf, N., Lee, J. H., Kapell, D., Zigman, W. B., Canto, B., Tycko, B., & Mayeux, R. P. (1996) · Annals of Neurology · doi:10.1002/ana.410400518 · Cited by 92
Self-citationHead, E., Lott, I. T., Patterson, D. W., Doran, E. W., & Haier, R. J. (2007) · Journal of Alzheimer s Disease · doi:10.3233/jad-2007-11110 · Cited by 91
Mucocutaneous Findings in 100 Children with Down Syndrome
Daneshpazhooh, M., NAZEMI, T. M., Bigdeloo, L., & YOOSEFI, M. (2007) · Pediatric Dermatology · doi:10.1111/j.1525-1470.2007.00412.x · Cited by 90
Lott, I. T. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.12.010 · Cited by 88
Prasher, V. P., Sajith, S. G., Rees, S. D., Patel, A., Tewari, S., Schupf, N., & Zigman, W. B. (2008) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2039 · Cited by 88
Self-citationTen-year survival of Down syndrome births
Hayes, C. B., Johnson, Z., Thornton, L., Fogarty, J. P., Lyons, R. A., O’Connor, M., Delany, V., & Buckley, K. (1997) · International Journal of Epidemiology · doi:10.1093/ije/26.4.822 · Cited by 85
Twenty‐Five–Year survival of children with birth defects in New York State: A population‐based study
Wang, Y., Hu, J., Druschel, C. M., et al. (2011) · Birth Defects Research Part A Clinical and Molecular Teratology · doi:10.1002/bdra.22858 · Cited by 83
Change in plasma Aβ peptides and onset of dementia in adults with Down syndrome
Schupf, N., Zigman, W. B., Tang, M. X., Pang, D. I., Mayeux, R. P., Mehta, P. D., & Silverman, W. P. (2010) · Neurology · doi:10.1212/wnl.0b013e3181fb448b · Cited by 81
Self-citationMäättä, T., Määttä, J., Tervo-Määttä, T., Taanila, A. M., Kaski, M., & Iivanainen, M. V. (2011) · Journal of Intellectual & Developmental Disability · doi:10.1080/13668250.2011.570253 · Cited by 80
Decreased AIRE Expression and Global Thymic Hypofunction in Down Syndrome
Lima, F. A., Moreira‐Filho, C. A., Ramos, P. L., Brentani, H., Lima, L. D. A., dos Santos, M. A., Bento-de-Souza, L. C., Bento‐de‐Souza, L., Duarte, M. I. S., Coutinho, A., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003053 · Cited by 80
Histopathologische Untersuchungen über Entstehung und Wesen der senilen Plaques
Struwe, F. E. (1929) · Zeitschrift für die gesamte Neurologie und Psychiatrie · doi:10.1007/bf02876635 · Cited by 79
An Updated Survey on Skin Conditions in Down Syndrome
Schepis, C., Barone, C., Siragusa, M., et al. (2002) · Dermatology · doi:10.1159/000065859 · Cited by 78
Longevity and the 2 Allele of Apolipoprotein E: The Finnish Centenarians Study
Frisoni, G. B., Louhija, J., Geroldi, C., & Trabucchi, M. (2001) · The Journals of Gerontology Series A · doi:10.1093/gerona/56.2.m75 · Cited by 78
Telomere shortening in T lymphocytes of older individuals with Down syndrome and dementia
Jenkins, E. C., Velinov, M. T., Ye, L., Gu, H., Li, S., Jenkins, E. C., Brooks, S. S., Pang, D. I., Devenny, D. A., Zigman, W. B., et al. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.05.021 · Cited by 77
Self-citationComparative survival advantage of males with down syndrome
Glasson, E. J., Sullivan, S. G., Hussain, R., Petterson, B., Montgomery, P., & Bittles, A. H. (2003) · American Journal of Human Biology · doi:10.1002/ajhb.10132 · Cited by 75
Incidence and Temporal Patterns of Adaptive Behavior Change in Adults With Mental Retardation
Zigman, W. B., Schupf, N., Urv, T. K., Zigman, A., & Silverman, W. P. (2002) · American Journal on Mental Retardation · doi:10.1352/0895-8017(2002)107<0161:iatpoa>2.0.co;2 · Cited by 74
Self-citationLow Blood Pressure in Down's Syndrome: A Link With Alzheimer's Disease?
Rd, M., McGrath, A., Davidson, G., Brown, J. J., Murray, G. D., & Lever, A. F. (1996) · Hypertension · doi:10.1161/01.hyp.28.4.569 · Cited by 72
APOE ε4 influences the manifestation of Alzheimer's disease in adults with Down's syndrome
Deb, S., Braganza, J., Norton, N., Williams, H., Kehoe, P. G., Williams, J., & Owen, M. J. (2000) · British Journal of Psychiatry · doi:10.1192/bjp.176.5.468 · Cited by 71
Age at onset of dementia and age of menopause in women with Down’s syndrome
Cosgrave, M., Tyrrell, J., McCarron, M., Gill, M., & LAWLOR, B. A. (1999) · Journal of Intellectual Disability Research · doi:10.1046/j.1365-2788.1999.00192.x · Cited by 71
Zigman, W. B., Schupf, N., Haveman, M. J., & Silverman, W. P. (1997) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.1997.tb00679.x · Cited by 71
Self-citationPsychiatric Symptoms in Adults With Down Syndrome and Alzheimer's Disease
Urv, T. K., Zigman, W. B., & Silverman, W. P. (2010) · American Journal on Intellectual and Developmental Disabilities · doi:10.1352/1944-7558-115.4.265 · Cited by 69
Self-citationAhnini, R. T., di Giovine, F. S., McDonagh, A. J. G., Messenger, A. G., Amadou, C., Cox, A., Duff, G. W., & Cork, M. J. (2000) · Human Genetics · doi:10.1007/s004390000318 · Cited by 68
van Buggenhout, G. J. C. M., Trommelen, J. C. M., Schoenmaker, A., Bal, C. D., Verbeek, J. J. M. C., Smeets, D., Ropers, H., Devriendt, K., Hamel, B. C. J., & Fryns, J. P. (1999) · American Journal of Medical Genetics · Cited by 68
Insulin resistance in adolescents with Down syndrome: a cross-sectional study
Fonseca, C. T., Amaral, D., Ribeiro, M. G., Beserra, I. C. R., & Guimarães, M. M. (2005) · BMC Endocrine Disorders · doi:10.1186/1472-6823-5-6 · Cited by 67
Goldgaber, D., Lerman, M. I., McBride, W. O., Saffiotti, U., & Gajdusek, D. C. (1987) · PubMed · Cited by 67
Schupf, N., Winsten, S., Patel, B. N., Pang, D. I., Ferin, M., Zigman, W. B., Silverman, W. P., & Mayeux, R. P. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.07.062 · Cited by 66
Self-citationDevelopmental Disabilities Grown Up: Down Syndrome
Steingass, K. J., Chicoine, B. A., McGuire, D. E., & Roizen, N. (2011) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0b013e31822182e0 · Cited by 66
Menopause in women with learning disabilities
Carr, J., & Hollins, S. C. (1995) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.1995.tb00481.x · Cited by 63
Inflammatory and Immunological parameters in adults with Down syndrome
Trotta, M. B. F., Serro‐Azul, J. B., Wajngarten, M., Fonseca, S. G., Goldberg, A. C., & Kalil, J. E. (2011) · Immunity & Ageing · doi:10.1186/1742-4933-8-4 · Cited by 63
Phenotypic and dermatological manifestations in Down Syndrome
Sureshbabu, R., Kumari, R., Ranugha, P. S. S., Sathyamoorthy, R., Udayashankar, C., & Oudeacoumar, P. (2011) · Dermatology Online Journal · doi:10.5070/d38jx5f2v2 · Cited by 62
What is the Proximal Cause of Aging?
Zimniak, P. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00189 · Cited by 62
Molecular Dating of Senile Plaques in the Brains of Individuals with Down Syndrome and in Aged Dogs
Azizeh, B. Y., Head, E., Ibrahim, M. A., Torp, R., Tenner, A. J., Kim, R. C., Lott, I. T., & Cotman, C. W. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7359 · Cited by 59
Dementia in Down's syndrome: Observations from a neurology clinic
Lott, I. T., & Lai, F. (1982) · Applied Research in Mental Retardation · doi:10.1016/0270-3092(82)90017-0 · Cited by 59
Prasher, V. P., Adams, C., & Holder, R. L. (2003) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.859 · Cited by 59
Successful Aging in a 70-Year-Old Man With Down Syndrome: A Case Study
Krinsky‐McHale, S. J., Devenny, D. A., Gu, H., Jenkins, E. C., Kittler, P. M., Murty, V. V., Schupf, N., Scotto, L., Tycko, B., Urv, T. K., et al. (2008) · Intellectual and developmental disabilities · doi:10.1352/2008.46:215-228 · Cited by 59
Self-citationLearning and memory as a function of age in Down syndrome: A study using animal-based tasks
Nelson, L. D., Johnson, J. K., Freedman, M., Lott, I. T., Groot, J., Chang, M., Milgram, N. W., & Head, E. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.12.009 · Cited by 58
Prasher, V. P., & Chung, M. C. (1996) · PubMed · Cited by 56
Chace, C., Pang, D., Weng, C., Temkin, A., Lax, S., Silverman, W., Zigman, W., Ferin, M., Lee, J. H., Tycko, B., et al. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110860 · Cited by 53
Brain anatomy and ageing in non-demented adults with Down's syndrome: anin vivoMRI study
Beacher, F. D. C. C., Daly, E., Simmons, A., Prasher, V. P., Morris, R. G., Robinson, C., Lovestone, S., Murphy, K. C., & Murphy, D. (2009) · Psychological Medicine · doi:10.1017/s0033291709990985 · Cited by 53
Six Degrees of Epistasis: Statistical Network Models for GWAS
McKinney, B. A., & Pajewski, N. (2011) · Front. Gene. · doi:10.3389/fgene.2011.00109 · Cited by 53
ApoE Genotype and Alzheimer's Disease in Adults With Down Syndrome: Meta-Analysis
Prasher, V. P., Chowdhury, T. A., Rowe, B. R., & Bain, S. C. (1997) · American Journal on Mental Retardation · doi:10.1352/0895-8017(1997)102<0103:agaadi>2.0.co;2 · Cited by 53
Mortality and survival for Down syndrome in Japan.
Masaki, M., Higurashi, M., Iijima, K., Ishikawa, N., Tanaka, F., Fujii, T., Kuroki, Y., Matsui, I., IINUMA, K., Matsuo, N., et al. (1981) · Europe PMC (PubMed Central) · Cited by 53
Stiffness of the large arteries in individuals with and without Down syndrome
Rodrigues, A., Coelho, Gonçalves, W. L. S., Gouvêa, Vasconcellos, Cunha, & Abreu (2011) · Vascular Health and Risk Management · doi:10.2147/vhrm.s21273 · Cited by 52
Down's syndrome: intellectual and behavioural functioning during adulthood
Fenner, M., Hewitt, K., & Torpy, D. (1987) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.1987.tb01367.x · Cited by 51
Granholm, A., Sanders, L., Seo, H., Lin, L., Ford, K. A., & Ole Isacson, A. (2003) · Hippocampus · doi:10.1002/hipo.10130 · Cited by 51
Gropman, A. L., & Batshaw, M. L. (2010) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0b013e3181ee384e · Cited by 49
Cholesterol level, statin use and Alzheimer's disease in adults with Down syndrome
Zigman, W. B., Schupf, N., Jenkins, E. C., Urv, T. K., Tycko, B., & Silverman, W. P. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.02.023 · Cited by 48
Self-citationSyndromes of accelerated aging.
Gm, M. (1982) · PubMed · Cited by 45
Prevalence of dementia in adult patients with trisomy 21
Franceschi, M., Comola, M., Piattoni, F., Gualandri, W., & Canal, N. (2005) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320370760 · Cited by 44
Preparing primary care for the future – perspectives from the Netherlands, England, and USA
Erler, A., Bodenheimer, T. S., Baker, R., Goodwin, N., Spreeuwenberg, C., Vrijhoef, H. J., Nolte, E., & Gerlach, F. M. (2011) · Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen · doi:10.1016/j.zefq.2011.09.029 · Cited by 41
Plasma β‐amyloid and duration of Alzheimer's disease in adults with Down syndrome
Prasher, V. P., Sajith, S. G., Mehta, P. D., Zigman, W. B., & Schupf, N. (2009) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2321 · Cited by 41
Self-citationAdipocytokines in Down's syndrome, an atheroma-free model: Role of adiponectin
Romanelli, M. M. C., Dogliotti, G., Pedroni, F., Galliera, E., Malavazos, A. E., Villa, R. E., Chiappelli, M., & Licastro, F. (2008) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2007.10.011 · Cited by 39
Jenkins, E. C., Ye, L., Gu, H., Ni, S. A., Duncan, C. J., Velinov, M. T., Pang, D. I., Krinsky‐McHale, S. J., Zigman, W. B., Schupf, N., et al. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.05.098 · Cited by 39
Self-citationShorter telomeres may indicate dementia status in older individuals with Down syndrome
Jenkins, E. C., Ye, L., Gu, H., Ni, S. A., Velinov, M. T., Pang, D. I., Krinsky‐McHale, S. J., Zigman, W. B., Schupf, N., & Silverman, W. P. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.06.001 · Cited by 38
Self-citationArmstrong, R. A., Myers, D., & Smith, C. U. M. (1993) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000107291 · Cited by 37
An association study of common variation at the MAPT locus with late‐onset Alzheimer's disease
Abraham, R., Sims, R., Carroll, L., Hollingworth, P., O’Donovan, M. C., Williams, J. H., & Owen, M. J. (2009) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30951 · Cited by 37
Age-related changes in plasma levels of BDNF in Down syndrome patients
Dogliotti, G., Galliera, E., Licastro, F., & Romanelli, M. M. C. (2010) · Immunity & Ageing · doi:10.1186/1742-4933-7-2 · Cited by 36
Apolopoprotein-E gene polymorphism and lipid profiles in Alzheimer's disease
İşbir, T., Ağaçhan, B., Yılmaz, H., Aydın, M., Kara, İ., Eker, E., & Eker, D. (2001) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/153331750101600207 · Cited by 33
Effect of menopause on cognitive performance in women with Down syndrome
Patel, B. N., Seltzer, G. B., Wu, H.-S., & Schupf, N. (2001) · Neuroreport · doi:10.1097/00001756-200108280-00014 · Cited by 33
Apo E genotypes and risk of dementia in Down syndrome
Rubinsztein, D. C., Hon, J., Stevens, F., Pyrah, I. T. G., Tysoe, C. J., Huppert, F. A., Easton, D. F., & Holland, A. J. (1999) · American Journal of Medical Genetics · Cited by 33
Natural history of thyroid function in adults with Down syndrome – 10‐year follow‐up study
Prasher, V. P., & Gomez, G. (2006) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.2006.00879.x · Cited by 32
Increased Survival following Tumorigenesis in Ts65Dn Mice That Model Down Syndrome
Yang, A., & Reeves, R. H. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4489 · Cited by 32
Maladaptive Behaviors Related to Adaptive Decline in Aging Adults With Mental Retardation
Urv, T. K., Zigman, W. B., & Silverman, W. P. (2003) · American Journal on Mental Retardation · doi:10.1352/0895-8017(2003)108<327:mbrtad>2.0.co;2 · Cited by 32
Self-citationFifteen-year follow-up of thyroid status in adults with Down syndrome
Prasher, V. P., Ninan, S., & Haque, S. M. (2011) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.2011.01384.x · Cited by 31
Down syndrome: is it really characterized by precocious immunosenescence?
Kusters, M., Verstegen, R. H. J., & de Vries, E. (2011) · Europe PMC (PubMed Central) · Cited by 31
Mortality is associated with apolipoprotein E ɛ4 in nondemented adults with Down syndrome
Zigman, W. B., Jenkins, E. C., Tycko, B., Schupf, N., & Silverman, W. P. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.08.002 · Cited by 31
Self-citationThe Prevalence of Dementia in Down Syndrome
Johannsen, P., Christensen, J. E. J., & Mai, J. (1996) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000106883 · Cited by 30
Neuropsychiatric Symptoms in Alzheimer's Disease and Vascular Dementia
Echávarri, C., Burgmans, S., Uylings, H. B. M., Cuesta, M. J., Peralta, V., Kamphorst, W., Rozemüller, A. J. M., & Verhey, F. R. J. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-121003 · Cited by 29
Estrogen Receptor-α Variants Increase Risk of Alzheimer’s Disease in Women with Down Syndrome
Schupf, N., Lee, J. H., Wei, M., Pang, D. I., Chace, C., Cheng, R., Zigman, W. B., Tycko, B., & Silverman, W. P. (2008) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000126495 · Cited by 29
Self-citationZhao, Q., Lee, J. H., Pang, D. I., Temkin, A. M., Park, N., Janicki, S. C., Zigman, W. B., Silverman, W. P., Tycko, B., & Schupf, N. (2011) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000334522 · Cited by 27
Self-citationŠustrová, M., & Strbák, V. (1994) · Journal of Endocrinological Investigation · doi:10.1007/bf03347724 · Cited by 24
The H1 Haplotype of the Tau Gene (MAPT) is Associated with Mild Cognitive Impairment
Maria, E. D., Cammarata, S., Parodi, M. I., Borghi, R., Benussi, L., Galli, M., Galimberti, D., Ghidoni, R., Gonella, D., Novello, C., et al. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1285 · Cited by 24
İşbir, T., Ağaçhan, B., Yılmaz, H., Aydın, M., Kara, İ., Eker, D., & Eker, E. (2001) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/153331750101600407 · Cited by 24
Jenkins, E. C., Ye, L., Velinov, M. T., Krinsky‐McHale, S. J., Zigman, W. B., Schupf, N., & Silverman, W. P. (2012) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32066 · Cited by 23
Self-citation
Cited by
Predicting Age Using Neuroimaging: Innovative Brain Ageing Biomarkers
Cole, J. H., & Franke, K. (2017) · Trends in Neurosciences · doi:10.1016/j.tins.2017.10.001 · Cited by 903
A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome
Wiseman, F. K., Al-Janabi, T., Hardy, J., Karmiloff-Smith, A., Nizetic, D., Tybulewicz, V. L. J., Fisher, E. M. C., & Strydom, A. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3983 · Cited by 562
Accelerated epigenetic aging in Down syndrome
Horvath, S., Garagnani, P., Bacalini, M. G., Pirazzini, C., Salvioli, S., Gentilini, D., Di Blasio, A. M., Giuliani, C., Tung, S., Vinters, H. V., et al. (2015) · Aging Cell · doi:10.1111/acel.12325 · Cited by 488
Brain age and other bodily ‘ages’: implications for neuropsychiatry
Cole, J. H., Marioni, R. E., Harris, S. E., & Deary, I. J. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0098-1 · Cited by 440
Dementia in Down syndrome: unique insights for Alzheimer disease research
Lott, I. T., & Head, E. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-018-0132-6 · Cited by 383
Metadata
- Authors
- Zigman, W. B.
- Venue
- Developmental Disabilities Research Reviews
- Publisher
- Wiley
- Published
- 2013-08
- Volume
- 18
- Issue
- 1
- Pages
- 51-67
- ISSN
- 1940-5510 (ISSN-L)
- 1940-5529
- OpenAlex
- W1575011814
- Cited by
- 260
- References
- 211
- FWCI
- 21.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.